These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Treatment of cerebral vascular insufficiency syndromes in old age. Controlled research by double blind technic]. Mars G; Nebuloni G G Gerontol; 1970 Mar; 18(3):153-76. PubMed ID: 4919664 [No Abstract] [Full Text] [Related]
28. Effect of cyclandelate upon cerebral blood flow in patients with "stroke". Kuhn RA Angiology; 1966 Jun; 17(6):422-30. PubMed ID: 5943177 [No Abstract] [Full Text] [Related]
29. Vasodilator action of Stugeron on the cerebral and peripheral arteries in the light of clinical observations. Less E Ther Hung; 1973; 21(3-4):140-5. PubMed ID: 4806424 [No Abstract] [Full Text] [Related]
30. [Long-term medical treatment of acute cerebrovascular disease sequelae (comparison papaverine-piribedil]. Piccinelli A; Neri G; Agnoli A Minerva Med; 1974 Nov; 65(80):4199-213. PubMed ID: 4610451 [No Abstract] [Full Text] [Related]
31. [Statistical studies on the results of stroke therapy]. Eichhorn O; Auell KH; Dörfler L Med Klin; 1965 Dec; 60(52):2100-4. PubMed ID: 5333324 [No Abstract] [Full Text] [Related]
32. The EEG treatment of hypoxic and other cerebral disorders by improvement of the blood supply. Flügel KA Electroencephalogr Clin Neurophysiol; 1967 Oct; 23(4):382. PubMed ID: 4167782 [No Abstract] [Full Text] [Related]
33. Vasodilating drugs and their use in cerebral symptomatology. Caplan LR J Maine Med Assoc; 1977 Sep; 68(9):333-8. PubMed ID: 925513 [No Abstract] [Full Text] [Related]
34. [Agents to improve cerebrovascular circulation and cerebral metabolism--cinepazide]. Fujishima M Nihon Rinsho; 1985 Feb; 43(2):379-82. PubMed ID: 3999408 [No Abstract] [Full Text] [Related]
35. Cerebral vasospasm, 1965. Thomas LM; Scratch GP; Gurdjian ES Minn Med; 1966 Jan; 49(1):55-8. PubMed ID: 5901199 [No Abstract] [Full Text] [Related]
36. [Trial of using Cavinton in cerebrovascular disorders]. Shtok VN; Eremeeva SV Klin Med (Mosk); 1982 Oct; 60(10):39-42. PubMed ID: 6757560 [No Abstract] [Full Text] [Related]
37. [Effect of Halidor on cerebral hemodynamics and metabolism in ischemic cerebral circulatory disorders]. Hadjiev D; Ganev G Orv Hetil; 1968 May; 109(21):Suppl:37-40. PubMed ID: 5720721 [No Abstract] [Full Text] [Related]
38. Double blind trial with suloctidil, a new vasoactive agent, in elderly patients with psycho-organic brain syndrome. Jacquy J; Noel G Acta Clin Belg; 1977; 32(1):22-6. PubMed ID: 331821 [No Abstract] [Full Text] [Related]
39. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination]. Hüdepohl M; Bockelmann R Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907 [No Abstract] [Full Text] [Related]
40. [What is assured in drug therapy of cerebrovascular circulation disorders?]. Gottstein U Med Klin; 1973 Jul; 68(29):947-51. PubMed ID: 4579835 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]